Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized multicenter phase 4 study of intraoperative lobaplatin peritoneal lavage in colorectal cancer surgery
ChiCTR1800014617Phase 4Recruiting
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Sep 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of lobaplatin in colorectal cancer (CRC) (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: Peritoneal metastasis rate. Started Sep 2017; status: recruiting.
02
Drugs
lobaplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on ChiCTR1800014617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014617.